Literature DB >> 1794359

Decreased incidence of infection after renal transplantation with the use of cyclosporine.

C d'Ivernois1, M Dupon, J F Dartigues, L Potaux, M Aparicio, J Y Lacut.   

Abstract

The incidence of infection within six months of cadaveric kidney transplantation was reviewed in 183 consecutive patients. Prior to June, 1985, 91 patients received azathioprine 2 mg/kg/day and prednisone 0.5 mg/kg/day; 63 patients (group A1) also received antilymphocyte globulin 15 mg/kg/day for the first ten days, whereas for the 28 other patients (group A2) antilymphocyte globulin had to be withdrawn before 72 hours because of general intolerance. The next 92 patients received cyclosporine 5-8 mg/kg/day and prednisone 0.25 mg/kg/day (group B). The three groups were similar for all studied parameters except for the number of patients with anti-HLA antibodies. At six months the mortality rate was not significantly different between the three groups. After six months the number of infections per patient was 1.47, 1.03 and 0.84 (p less than 0.01) in groups A1, A2 and B respectively; the percentage of patients developing one or more infections was 81, 58 and 57% (p less than 0.01); bacterial infections: 57, 50 and 34% (p less than 0.01); viral infections: 40, 14 and 10% (p less than 0.01); cytomegalovirus infections: 27, 11 and 4% (p less than 0.001). After adjustment with logistic regression upon factors which might facilitate infections, the results showed a significantly lower incidence of infection for the cyclosporine-treated group, especially for cytomegalovirus, as compared with the antilymphocyte globulin-treated group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794359     DOI: 10.1007/BF02005443

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem.

Authors:  P K Peterson; R Ferguson; D S Fryd; H H Balfour; J Rynasiewicz; R L Simmons
Journal:  Medicine (Baltimore)       Date:  1982-11       Impact factor: 1.889

2.  Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation.

Authors:  M J Bia; W Andiman; K Gaudio; A Kliger; N Siegel; D Smith; W Flye
Journal:  Transplantation       Date:  1985-12       Impact factor: 4.939

3.  Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.

Authors:  U J Hesse; D S Fryd; S N Chatterjee; R L Simmons; D E Sutherland; J S Najarian
Journal:  Arch Surg       Date:  1986-09

4.  Triple therapy in cadaver renal transplantation.

Authors:  R M Jones; J A Murie; R D Allen; A Ting; P J Morris
Journal:  Br J Surg       Date:  1988-01       Impact factor: 6.939

5.  Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.

Authors: 
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

6.  Infections in renal transplant patients treated with cyclosporine or azathioprine.

Authors:  W T van Dorp; A M Kootte; G W van Gemert; L A van Es; L C Paul
Journal:  Scand J Infect Dis       Date:  1989

7.  Early infections in kidney, heart, and liver transplant recipients on cyclosporine.

Authors:  J S Dummer; A Hardy; A Poorsattar; M Ho
Journal:  Transplantation       Date:  1983-09       Impact factor: 4.939

8.  Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.

Authors:  M L Henry; B G Sommer; R M Ferguson
Journal:  Am J Surg       Date:  1985-11       Impact factor: 2.565

9.  A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.

Authors:  J S Najarian; D S Fryd; M Strand; D M Canafax; N L Ascher; W D Payne; R L Simmons; D E Sutherland
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

10.  A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.

Authors: 
Journal:  N Engl J Med       Date:  1986-05-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.